Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ) Overview

  • Status
  • Acquired/​Merged

  • Employees
  • 40

Employees

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ) General Information

Description

30,900 square-foot commercial-scale cell therapy manufacturing facility in Princeton, New Jersey. The facility houses 16 suites positioned for the production of products in a cGMP-compliant manner, as well as laboratories for analytical, quality control and microbiology testing.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • University Square Campus Park
  • Princeton, NJ
  • United States
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Biotechnology
Acquirer
Corporate Office
  • University Square Campus Park
  • Princeton, NJ
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ)‘s full profile, request access.

Request a free trial

Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ)‘s full profile, request access.

Request a free trial

Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ) FAQs

  • Where is Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ) headquartered?

    Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ) is headquartered in Princeton, NJ.

  • What is the size of Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ)?

    Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ) has 40 total employees.

  • What industry is Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ) in?

    Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ)’s primary industry is Buildings and Property.

  • Is Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ) a private or public company?

    Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ) is a Private company.

  • What is the current valuation of Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ)?

    The current valuation of Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ) is .

  • What is Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ)’s current revenue?

    The current revenue for Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ) is .

  • Who are Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ)’s investors?

    Phaxiam has invested in Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ).

  • When was Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ) acquired?

    Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ) was acquired on 12-Apr-2022.

  • Who acquired Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ)?

    Erytech Pharma (30,900 sq.ft. Commercial Scale Cell Therapy Manufacturing Facility in Princeton, NJ) was acquired by Catalent.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process